Rezo Therapeutics’ $78 Million Series A Financing

Wilson Sonsini represented lead investors SR One and Norwest in the transaction.Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now